These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4984273)

  • 41. [False-positive ocular pigmentation during administration of neuroleptics].
    Tidsskr Nor Laegeforen; 1971 Dec; 91(35):2575-6. PubMed ID: 4945027
    [No Abstract]   [Full Text] [Related]  

  • 42. Therapy of Phenothiazine-produced skin pigmentation: a preliminary report.
    Gibbard BA; Lehmann HE
    Am J Psychiatry; 1966 Sep; 123(3):351-2. PubMed ID: 5917622
    [No Abstract]   [Full Text] [Related]  

  • 43. Ocular pigmentation, extrapyramidal symptoms and phenothiazine dosage.
    Wheeler RH; Bhalerao VR; Gilkes MJ
    Br J Psychiatry; 1969 Jun; 115(523):687-90. PubMed ID: 5806859
    [No Abstract]   [Full Text] [Related]  

  • 44. Ocular complications of systemic medications.
    Ellis PP
    Tex Med; 1971 Apr; 67(4):70-3. PubMed ID: 5552586
    [No Abstract]   [Full Text] [Related]  

  • 45. Ocular and cutaneous side effects after prolonged chlorpromazine treatment.
    Gombos GM; Yarden PE
    Am J Psychiatry; 1967 Jan; 123(7):872-4. PubMed ID: 6016858
    [No Abstract]   [Full Text] [Related]  

  • 46. [Ultrastructural study of ocular pigmentation due to phenothiazines].
    Sizaret P; Rossazza C; Brassart B
    Rev Otoneuroophtalmol; 1975; 47(4):247-51. PubMed ID: 1215727
    [No Abstract]   [Full Text] [Related]  

  • 47. Scleral discoloration associated with long-term prednisone administration.
    Henderson RP; Lander R
    Cutis; 1984 Jul; 34(1):76-7. PubMed ID: 6432448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chlorpromazine and the eye of the dog. IV. Reversibility of ocular lesions.
    Barron CN; Rubin LF; Steelman RL
    Exp Mol Pathol; 1972 Apr; 16(2):163-8. PubMed ID: 5062560
    [No Abstract]   [Full Text] [Related]  

  • 49. The ocular manifestations and functional effects of occupational argyrosis.
    Moss AP; Sugar A; Hargett NA; Atkin A; Wolkstein M; Rosenman KD
    Arch Ophthalmol; 1979 May; 97(5):906-8. PubMed ID: 312638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chlorpromazine.
    Macri F
    Eye Ear Nose Throat Mon; 1971 Mar; 50(3):111-2. PubMed ID: 5552871
    [No Abstract]   [Full Text] [Related]  

  • 51. [Ocular repercussions during treatment with cordarone].
    Darleguy P; Blade J; Gacon R; Riu R
    Bull Soc Ophtalmol Fr; 1971 Jan; 71(1):82-7. PubMed ID: 5113101
    [No Abstract]   [Full Text] [Related]  

  • 52. [Ten-year follow-up study on ocular manifestations of "yusho" (accidental polychlorinated biphenyls poisoning) (author's transl)].
    Kohno TK; Yamana Y
    Fukuoka Igaku Zasshi; 1979 Apr; 70(4):181-6. PubMed ID: 113314
    [No Abstract]   [Full Text] [Related]  

  • 53. [Pigmentation of the skin: rare side effect, following the prolonged administration of high doses of chlorpromazine].
    Lehmann HE; Gallai Z; Ban TA
    Ann Dermatol Syphiligr (Paris); 1965; 92(3):287-9. PubMed ID: 5841181
    [No Abstract]   [Full Text] [Related]  

  • 54. Chlorpromazine purple people.
    Trans St Johns Hosp Dermatol Soc; 1966; 52(1):90-1. PubMed ID: 5944914
    [No Abstract]   [Full Text] [Related]  

  • 55. Ocular adverse reactions to drugs.
    Crews SJ
    Practitioner; 1977 Jul; 219(1309):72-7. PubMed ID: 887552
    [No Abstract]   [Full Text] [Related]  

  • 56. Re: Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
    O'Croinin F; Zibin T
    J Psychiatry Neurosci; 1994 May; 19(3):226. PubMed ID: 8031748
    [No Abstract]   [Full Text] [Related]  

  • 57. Chlorpromazine-induced anterior segment changes.
    Brooks JG; Matoba AY
    Arch Ophthalmol; 1992 Jan; 110(1):126. PubMed ID: 1731707
    [No Abstract]   [Full Text] [Related]  

  • 58. Incidence and significance of chlorpromazine-induced eye changes.
    De Long SL
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:19-22. PubMed ID: 4876741
    [No Abstract]   [Full Text] [Related]  

  • 59. Pigmentation and retinopathy due to chloroquine.
    Stewart TW; Miles DW; Earnshaw ER
    Acta Derm Venereol; 1968; 48(1):47-52. PubMed ID: 4174103
    [No Abstract]   [Full Text] [Related]  

  • 60. [Eye and skin complications with long-term treatment of psychopharmaceutic agents].
    Gunby B
    Nord Psykiatr Tidsskr; 1967; 21(5):378-88. PubMed ID: 5587721
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.